How many insider trades does FilingIQ track for DCOY?

FilingIQ tracks 10 Form 4 insider transactions for DCOY (SALARIUS PHARMACEUTICALS INC (US)), covering filings from Aug 31, 2026 onwards. 10 of those were filed in the last 90 days.

Are DCOY insiders net buyers or net sellers?

Across the full Form 4 history for DCOY, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DCOY insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DCOY in?

SALARIUS PHARMACEUTICALS INC (US) (DCOY) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.74M.

DCOY insider trading

NasdaqCM Healthcare

SALARIUS PHARMACEUTICALS INC (US) — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$4.74M

About SALARIUS PHARMACEUTICALS INC (US)

Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Cambridge, Massachusetts.

Company website: decoytx.com

DCOY insider activity at a glance

FilingIQ has scored 10 insider transactions for DCOY since Aug 31, 2026. The most recent filing in our index is dated Aug 31, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live DCOY trades on FilingIQ

Other Healthcare tickers with recent insider activity

UTHR 806

UNITED THERAPEUTICS Corp

BLLN 188

BillionToOne, Inc.

KYMR 166

Kymera Therapeutics, Inc.

ONC 158

BeOne Medicines Ltd.

TMO 130

THERMO FISHER SCIENTIFIC INC.

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for DCOY?: FilingIQ tracks 10 Form 4 insider transactions for DCOY (SALARIUS PHARMACEUTICALS INC (US)), covering filings from Aug 31, 2026 onwards. 10 of those were filed in the last 90 days.
Are DCOY insiders net buyers or net sellers?: Across the full Form 4 history for DCOY, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DCOY insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DCOY in?: SALARIUS PHARMACEUTICALS INC (US) (DCOY) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.74M.

Methodology & sources

Every DCOY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.